Exchange: NASDAQ·Updated 04:00 PM EDT
XBIO logo

XBIO Xenetic Biosciences Inc

$2.19
$0.01
(0.47%)
Today
Closed $2.13
$0.06
(2.82%)
After Hours
Mkt Cap$4.97M
Vol10,232.00

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
42

Bearish Sentiment

How do you feel about XBIO?

Rolo2024
$XBIO How can this be ranked so high Bullish when thus stock just took a 50% hit?! They only get 15% of the newly formed company. Any longs happy about this outcome? Very confused.
2
focafoca99
$XBIO released an updated investor presentation outlining its pending acquisition of Santersus.
1
Biscroke
$XBIO 👀 looking for it to close the gap, next week should show if it makes a move for it or rejects and goes back down
1
Invescent
📉 $XBIO Top Loser #1 Move: down 50.3% 🔴 Financial Health: Weak • 0/100 🔴 Cash Flow Strength: Weak • Free cash flow -$2.29M 🔴 Profitability: Weak • Net margin -90.1% 🟡 Valuation: Not Meaningful • P/E is not meaningful because earnings are negative; P/S is 1.24 Analysis: Xenetic Biosciences, Inc. shows a weak financial profile. Not financial advice.
1
zsk78
$XBIO incorporating Santersus to combine different approaches targeting these NET’s is really intriguing. Not buying here based on chart but on watch moving forward.. there’s significant real world implications if this merger and tech is successful.
1
zoomlik
$XBIO Normally , they announce a cash infusion with this type of merger to validate combined merger valuation. None here seems so Also, needs to raise cash via selling shares of public company ?
GreedyBastard4Ever
$XBIO Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics

Advertisement|Remove ads.